Dare Bioscience (DARE)
(Delayed Data from NSDQ)
$3.09 USD
-0.54 (-14.88%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $3.07 -0.02 (-0.65%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.66 |
EPS Last Quarter | -0.84 |
Last EPS Surprise | -16.67% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.00 |
Next Year | 1.32 |
EPS (TTM) | -3.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.60M | 3.10M | 8.60M | 59.50M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 0.60M | 3.10M | 9.30M | 59.50M |
Low Estimate | 0.60M | 3.10M | 7.90M | 59.50M |
Year ago Sales | 0.00M | 1.00M | 2.81M | 8.60M |
Year over Year Growth Est. | NA | 210.00% | 206.30% | 591.78% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.66 | -0.84 | -3.00 | 1.32 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.60 | -0.84 | -2.76 | 1.32 |
High Estimate | -0.60 | -0.84 | -2.76 | 1.32 |
Low Estimate | -0.72 | -0.84 | -3.24 | 1.32 |
Year ago EPS | -1.20 | -1.08 | -4.20 | -3.00 |
Year over Year Growth Est. | 45.00% | 22.22% | 28.57% | 144.06% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.66 | -0.84 | -3.00 | 1.32 |
7 Days Ago | -0.66 | -0.84 | -3.00 | 1.32 |
30 Days Ago | -0.66 | -0.84 | -3.00 | 1.32 |
60 Days Ago | -0.60 | -0.96 | -2.94 | 1.20 |
90 Days Ago | -0.60 | -0.96 | -2.94 | -4.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.66 | -0.84 | -3.00 | 1.32 |
Zacks Consensus Estimate | -0.66 | -0.84 | -3.00 | 1.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.84 | -0.72 | -1.08 | -1.20 | NA |
Estimate | -0.72 | -1.44 | -1.20 | -1.20 | NA |
Difference | -0.12 | 0.72 | 0.12 | 0.00 | 0.18 |
Surprise | -16.67% | 50.00% | 10.00% | 0.00% | 10.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more